Abiopharma

News list

Director Teirlinck Didier P 🟢 acquired 123 shares (1 derivative) of ESAB Corp (ESAB) Transaction Date: Mar 31, 2026 | Filing ID: 000005

Full text

News bot April 1, 2026, 8:46 p.m.
🔍 Teirlinck Didier P (Director)

Company: ESAB Corp (ESAB)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 123
Detailed Transactions and Holdings:
- Acquired 123 shares of Deferred Stock Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 123.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each deferred stock unit represents a contingent right to receive one share of ESAB common stock.
- F2: These deferred stock units were issued in lieu of the director's cash retainer for Board service and vest immediately. The units will be settled in ESAB common stock after the director's separation from the Company.